← Eichor
Study identifier: NCT06263647 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Launching the Houston Hospital-Based Violence Intervention Program (Houston-HVIP): Developing and Evaluating a Hospital-Based Intervention to Reduce Recurrent Violence

Condition: Firearm Injury  ·  Sponsor: The University of Texas Health Science Center, Houston

PhaseNA
Planned participants274
Who can joinAll sexes, 16 Years to 35 Years
Healthy volunteersNo

About this study

A prior violent injury is one of the strongest predictors of future violent injury, highlighting the importance of effective hospital-based interventions to prevent reinjury. This project will establish and evaluate the Houston Hospital-Based Violence Intervention Program (Houston-HVIP). Using a randomized controlled trial, the study will assess the effectiveness of Houston-HVIP in reducing violent reinjury and improving behavioral, mental, and physical health outcomes over a 12-month follow-up period among those enrolled in the study in ages 16-35 years of age.

This description comes directly from the study's public registry record.

Talk to the study team

Sandra McKay, MD  ·  (713) 500-5666  ·  Sandra.McKay@uth.tmc.edu

Alexander Testa, PhD  ·  (210) 276-9000  ·  Alexander.Testa@uth.tmc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

The University of Texas Health Science Center at HoustonHouston, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06263647